Strata Critical Medical, Inc. (SRTA) vs Starling Oncology, Inc. (STLN)
- Strata Critical Medical, Inc. SRTA 4.54 +4.61%
- Starling Oncology, Inc. STLN 6.43 −6.95%
Strata Critical Medical, Inc. and Starling Oncology, Inc. are both Medical Care Facilities companies. Starling Oncology, Inc. is the larger, with a market value of $690.9M against $384.0M — 1.8× the size. Starling Oncology, Inc. has negative trailing earnings, so its P/E is not meaningful; Strata Critical Medical, Inc. trades at 9.0×. Strata Critical Medical, Inc. grew revenue faster over the last twelve months: 136.1% against 38.4%. Strata Critical Medical, Inc. has the higher net margin (15.7% vs −6.18%) and the higher return on invested capital (−4.98% vs −117.7%). Across the 17 metrics below, Strata Critical Medical, Inc. leads on 9 and Starling Oncology, Inc. on 8.
Valuation
Profitability
| Metric | SRTA | STLN | Medical Care Facilities median |
|---|---|---|---|
| Gross margin | 21.25% | 15.69% | 30.78% |
| Operating margin | (7.97%) | (4.44%) | 5.74% |
| Net margin | 15.71% | (6.18%) | 2.32% |
| Free cash flow margin | (19.34%) | (0.56%) | 5.46% |
| Return on equity | 16.01% | 214.12% | 8.76% |
| Return on assets | 13.62% | (21.47%) | 2.18% |
| Return on invested capital | (4.98%) | (117.66%) | 5.01% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack